Global Human ALDH2 Gene Polymorphism Detection Kits Market Strategic Research Report

Scope of the Report

The global Human ALDH2 Gene Polymorphism Detection Kits market size is predicted to grow from US$ 21.67 million in 2025 to US$ 40.87 million in 2032; it is expected to grow at a CAGR of 9.7% from 2026 to 2032.

ALDH2 stands for acetaldehyde dehydrogenase 2. Humans' understanding of acetaldehyde dehydrogenase (ALDH) stems from the alcohol metabolism pathway. ALDH is a key enzyme in alcohol metabolism. After drinking, ethanol in the body is mainly metabolized in the liver. Alcohol dehydrogenase (ADH) in the liver is responsible for oxidizing ethanol to acetaldehyde. The generated acetaldehyde is further converted into harmless acetic acid under the catalysis of ALDH as a substrate. At present, at least 19 ALDH isoenzymes have been identified, the most common of which are ALDH1-ALDH4. Among them, ALDH2 plays a major role in the oxidation of acetaldehyde.

ALDH2 is a key enzyme in alcohol metabolism in the human body, responsible for converting toxic acetaldehyde, a secondary metabolite of alcohol, into non-toxic acetic acid. ALDH2 gene mutations can reduce the body's ability to detoxify acetaldehyde. At the same time, ALDH2 gene mutations can also lead to a decrease in the body's ability to metabolize nitroglycerin to form nitric oxide (NO), increasing the risk of ineffective nitroglycerin. In addition, ALDH2*2 mutation is also a genetic risk factor for a variety of chronic diseases, such as cardiovascular disease, cancer and late-onset Alzheimer's disease.

The human ALDH2 gene polymorphism detection kit is used to detect the ALDH2 genotype in genomic DNA extracted from the patient's peripheral blood. The test results only represent the test results of the ALDH2 genotype. It can effectively test the alcohol metabolism ability of ALDH2*2 mutation carriers, guide personalized drinking, and evaluate individual nitrate esterase activity to guide the correct use of emergency drug nitroglycerin. In addition, it can also indicate the risk of diseases related to ALDH2 mutations, strengthen disease prevention and guide healthy lifestyles.

Global key Human ALDH2 Gene Polymorphism Detection Kits players cover Sansure Biotech, Wuhan Easy Diagnosis Biomedicine, Wuhan HealthCare Biotechnology, Hangzhou DIAN Biotechnology, Wuhan Hygeianey Bioscience, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human ALDH2 Gene Polymorphism Detection Kits market?

What factors are driving Human ALDH2 Gene Polymorphism Detection Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human ALDH2 Gene Polymorphism Detection Kits market opportunities vary by end market size?

How does Human ALDH2 Gene Polymorphism Detection Kits break out by Type, by Application?

This report presents a comprehensive overview of the global Human ALDH2 Gene Polymorphism Detection Kits market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• PCR Fluorescent Probe Method
• PCR Fluorescent Melting Curve Method

Segment by Application

• Hospital
• Medical Research Institute
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Human ALDH2 Gene Polymorphism Detection Kits market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Medical Research Institute, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact